TABLE 1.

Summary of patient demographic and clinical characteristics

				VFL
Case No.	Sex	Age (yrs)*	Ep Dur (yrs)	BL	Postop	Cognitive Outcome†	Path	Sz Freq/Mo	Sz Type	EC‡	AEDs
1	M	26	21	24	32	Good	Atrophy	1	CPS, SPS, CPS/G	A	Levetiracetam, lamotrigine
2	M	28	12	19	12	Poor	Enlarge (horn)	2	CPS, CPS/G	A	Levetiracetam, oxcarbazepine
3	F	41	36	11	3	Poor	MTS	16	CPS, SPS	C	Levetiracetam, valproic acid, phenobarbital
4	M	30	11	21	20	Good	MTS	2	CPS, GTC	A	Levetiracetam
5	F	50	31	21	13	Poor	Atrophy	7	CPS, CPS/G	C	Phenytoin
6	M	47	42	21	11	Poor	Hippo atrophy	15	CPS	A	Carbamazepine, irbesartan
7	F	42	4	18	8	Poor	MTS	1	CPS	A	Lamotrigine, methimazole
8	F	32	8	17	18	Good	MTS	1	CPS, CPS/G	C	Lamotrigine, carbamazepine
9	F	53	40	13	18	Good	MTS	5	CPS, GTC	A	Lamotrigine, carbamazepine
10	M	65	45	16	20	Good	Hippo atrophy	7	CPS	A	Topiramate, olanzapine
11	F	39	26	16	21	Good	Hippo atrophy	1	CPS	A	Valproic acid, phenobarbital, carbamazepine
12	M	60	56	18	11	Poor	MTS	2	CPS, SPS	A	Levetiracetam
13	F	52	32	23	17	Poor	Enlarge (horn)	1	CPS, GTC	A	Lamotrigine, carbamazepine
14	F	41	37	26	25	Good	MTS	2	CPS, GTC	A	Venlafaxine, lamotrigine, levetiracetam
15	F	26	5	14	17	Good	Atrophy	20	CPS	A	Diazepam, levetiracetam, topiramate
Mean (SD)		42 (12)	27 (16)	18 (4)	16 (7)			5 (6)

AEDs = antiepileptic drugs; BL = baseline; CPS = complex partial seizures; CPS/G = complex partial seizures with secondary generalization; EC = postsurgical Engel Class I subscore; enlarge = enlargement; Ep Dur = epilepsy duration; GTC = generalized tonic-clonic seizures; Hippo = hippocampal; MTS = mesial temporal sclerosis; Path = temporal lobe pathology; SPS = simple partial seizures; Sz = seizure; VFL = verbal (semantic) fluency.

^*Age at baseline scan.

^†Based on RCI.